Results for this period
Interim period (second quarter)1 December 2025–31 May 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Although sales of dairy ingredients struggled due to weak demand for dairy ingredients and cheese and the impact of measures to address inventories of domestically produced skim milk powder, sales of meat ingredients, life sciences products, and cheese manufactured and sold in Asia performed well, and net sales increased due to higher selling prices resulting from the weaker yen. Profit declined because the ¥650 million compensation income received in the previous year was absent, profit margins fell as expenses were recognized ahead of related revenues, and selling, general and administrative expenses increased, mainly due to the relocation of the head office.
No applicable matters ("There are no applicable matters")
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 December 2025–31 May 2026 |
| Net Sales | ¥97,866 million (YoY +2.7%) |
| Operating profit | ¥2,781 million (YoY -22.1%) |
| Ordinary income | ¥2,475 million (YoY -35.4%) |
| Profit attributable to owners of the parent | ¥1,748 million (YoY -37.5%) |
| Net income per share | ¥175.03 |
| Equity ratio | End of the current fiscal period 33.3 / End of previous period 35.9 |
| Total assets | ¥100,371 million |
| Net assets | ¥33,385 million |
| Cash flows from operating activities | ¥-2,239 million |
| Cash flows from investing activities | ¥-2,231 million |
| Cash flows from financing activities | ¥5,830 million |
| Cash and cash equivalents at end of period | ¥10,999 million |
| Full-year earnings forecast | Net Sales ¥193,000 million (YoY +5.6%) / Operating profit Not disclosed / Ordinary income ¥4,800 million (YoY -17.2%) / Net income ¥3,450 million (YoY -20.1%) |
| Annual Dividend Forecast | ¥132 → ¥132（0.0%） |
| Depreciation and amortization | ¥230 million |
| Disclosure regarding the going concern assumption | No applicable matters ("There are no applicable matters") |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies (company name: —) / Excluded 0 companies (company name: —) |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for analysts and institutional investors) |
| Issued Shares at Period-End | 10,050,200 shares |
| Treasury Shares at Period-End | 39,592 shares |
| Factors Behind Changes in Business Performance | Although sales of dairy ingredients struggled due to weak demand for dairy ingredients and cheese and the impact of measures to address inventories of domestically produced skim milk powder, sales of meat ingredients, life sciences products, and cheese manufactured and sold in Asia performed well, and net sales increased due to higher selling prices resulting from the weaker yen. Profit declined because the ¥650 million compensation income received in the previous year was absent, profit margins fell as expenses were recognized ahead of related revenues, and selling, general and administrative expenses increased, mainly due to the relocation of the head office. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Although sales of dairy ingredients struggled amid weak domestic demand for dairy ingredients and cheese and the impact of measures to address inventories of domestically produced skim milk powder, sales of meat ingredients, life sciences products, and cheese manufactured and sold in Asia performed well. Net sales also increased due in part to higher selling prices resulting from the weaker yen. Profit declined because the ¥650 million compensation income received in the previous year was absent, certain expenses were recognized ahead of related revenues in some transactions, and selling, general and administrative expenses increased, mainly due to the relocation of the head office.